Načítá se...
Down-Regulation of MYCN Protein by CX-5461 Leads to Neuroblastoma Tumor Growth Suppression
PURPOSE: MYCN oncogene amplification is an independent predictor of poor prognosis in neuroblastoma. CX-5461 is a small molecular inhibitor that prevents initiation of ribosomal RNA (rRNA) synthesis by RNA Pol I, down-regulating MYCN/MYC proteins. We hypothesize that neuroblastoma tumor growth can b...
Uloženo v:
| Vydáno v: | J Pediatr Surg |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6545249/ https://ncbi.nlm.nih.gov/pubmed/30879743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpedsurg.2019.02.028 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|